Research News
Share:
BySpondylitis Association of America

Upadacitinib (Rinvoq) Approved for Non-Radiographic Axial Spondyloarthritis

Upadacitinib is approved for the treatment of adults with active nr-axSpA who have objective signs of inflammation, and…

Read more
BySpondylitis Association of America

Physical Activity Shown to Improve Overall Functioning in Axial Spondyloarthritis

Physical activity and exercise have long been considered an important part of…

Read more
BySpondylitis Association of America

Biologic Ustekinumab (Stelara) Approved for Juvenile Psoriatic Arthritis

Ustekinumab (Stelara), a biologic medication that inhibits the IL-12 and IL-23 cytokines, has gained FDA approval for the…

Read more
BySpondylitis Association of America

Eating Prunes Every Day Could Keep Bone Loss Away

Consuming five to six prunes daily preserved bone density in postmenopausal women,…

Read more
ByJames T. Rosenbaum, MD

Medications to Treat or Prevent COVID-19

Vaccination remains the first line of defense against COVID-19 for those who live with spondyloarthritis (SpA)...

Read more
BySpondylitis Association of America

SPARTAN Conference Spotlights the Latest Spondyloarthritis Research

Meeting in person for the first time since the start of the pandemic, the 2022 SPARTAN conference featured…

Read more
1 2 3 18